[1] Yang, H. M., Liao, M. F., Zhu, S. Y., Liao, M. N., & Rohdewald, P. (2007). A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women. Acta obstetricia et gynecologica Scandinavica, 86(8), 978–985. [2] Enseleit, F., Sudano, I., Périat, D., Winnik, S., Wolfrum, M., Flammer, A. J., Fröhlich, G. M., Kaiser, P., Hirt, A., Haile, S. R., Krasniqi, N., Matter, C. M., Uhlenhut, K., Högger, P., Neidhart, M., Lüscher, T. F., Ruschitzka, F., & Noll, G. (2012). Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. European heart journal, 33(13), 1589–1597. [3] Pütter, M., Grotemeyer, K. H., Würthwein, G., Araghi-Niknam, M., Watson, R. R., Hosseini, S., & Rohdewald, P. (1999). Inhibition of smoking-induced platelet aggregation by aspirin and pycnogenol. Thrombosis research, 95(4), 155–161. |